191 related articles for article (PubMed ID: 36841851)
21. Oligodendroglioma resection: a Surveillance, Epidemiology, and End Results (SEER) analysis.
Alattar AA; Brandel MG; Hirshman BR; Dong X; Carroll KT; Ali MA; Carter BS; Chen CC
J Neurosurg; 2018 Apr; 128(4):1076-1083. PubMed ID: 28498059
[TBL] [Abstract][Full Text] [Related]
22. Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study.
Gao P; Huang XZ; Song YX; Sun JX; Chen XW; Sun Y; Jiang YM; Wang ZN
BMC Cancer; 2018 Mar; 18(1):234. PubMed ID: 29490625
[TBL] [Abstract][Full Text] [Related]
23. Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification.
Press RH; Shafer SL; Jiang R; Buchwald ZS; Abugideiri M; Tian S; Morgan TM; Behera M; Sengupta S; Voloschin AD; Olson JJ; Hasan S; Blumenthal DT; Curran WJ; Eaton BR; Shu HG; Zhong J
Cancer; 2020 Jul; 126(14):3255-3264. PubMed ID: 32342992
[TBL] [Abstract][Full Text] [Related]
24. Time to Surgery and Breast Cancer Survival in the United States.
Bleicher RJ; Ruth K; Sigurdson ER; Beck JR; Ross E; Wong YN; Patel SA; Boraas M; Chang EI; Topham NS; Egleston BL
JAMA Oncol; 2016 Mar; 2(3):330-9. PubMed ID: 26659430
[TBL] [Abstract][Full Text] [Related]
25. Improved survival of glioblastoma patients treated at academic and high-volume facilities: a hospital-based study from the National Cancer Database.
Zhu P; Du XL; Zhu JJ; Esquenazi Y
J Neurosurg; 2019 Feb; 132(2):491-502. PubMed ID: 30771780
[TBL] [Abstract][Full Text] [Related]
26. Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly.
Shirvani SM; Jiang J; Chang JY; Welsh J; Likhacheva A; Buchholz TA; Swisher SG; Smith BD
JAMA Surg; 2014 Dec; 149(12):1244-53. PubMed ID: 25321323
[TBL] [Abstract][Full Text] [Related]
27. A Comparison of the NCDB and SEER Database for Research Involving Head and Neck Cancer.
Janz TA; Graboyes EM; Nguyen SA; Ellis MA; Neskey DM; Harruff EE; Lentsch EJ
Otolaryngol Head Neck Surg; 2019 Feb; 160(2):284-294. PubMed ID: 30129822
[TBL] [Abstract][Full Text] [Related]
28. Extent of resection and survival outcomes of geriatric patients with glioblastoma: Is there benefit from aggressive surgery?
Lopez-Rivera V; Dono A; Lewis CT; Chandra A; Abdelkhaleq R; Sheth SA; Ballester LY; Esquenazi Y
Clin Neurol Neurosurg; 2021 Mar; 202():106474. PubMed ID: 33454497
[TBL] [Abstract][Full Text] [Related]
29. Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma.
Wang C; Kaprealian TB; Suh JH; Kubicky CD; Ciporen JN; Chen Y; Jaboin JJ
Neuro Oncol; 2017 Sep; 19(9):1263-1270. PubMed ID: 28371851
[TBL] [Abstract][Full Text] [Related]
30. Limb-sparing surgery plus radiotherapy results in superior survival: an analysis of patients with high-grade, extremity soft-tissue sarcoma from the NCDB and SEER.
Ramey SJ; Yechieli R; Zhao W; Kodiyan J; Asher D; Chinea FM; Patel V; Reis IM; Wang L; Wilky BA; Subhawong T; Trent JC
Cancer Med; 2018 Sep; 7(9):4228-4239. PubMed ID: 30030882
[TBL] [Abstract][Full Text] [Related]
31. Incidence and Outcome of Breast Biopsy Procedures During Follow-up After Treatment for Breast Cancer.
van la Parra RFD; Liao K; Smith BD; Yang WT; Leung JWT; Giordano SH; Kuerer HM
JAMA Surg; 2018 Jun; 153(6):559-568. PubMed ID: 29387884
[TBL] [Abstract][Full Text] [Related]
32. Concurrent chemoradiotherapy versus radiotherapy alone for "biopsy-only" glioblastoma multiforme.
Kole AJ; Park HS; Yeboa DN; Rutter CE; Corso CD; Aneja S; Lester-Coll NH; Mancini BR; Knisely JP; Yu JB
Cancer; 2016 Aug; 122(15):2364-70. PubMed ID: 27172136
[TBL] [Abstract][Full Text] [Related]
33. Patterns of care and outcomes in gliosarcoma: an analysis of the National Cancer Database.
Frandsen J; Orton A; Jensen R; Colman H; Cohen AL; Tward J; Shrieve DC; Suneja G
J Neurosurg; 2018 Apr; 128(4):1133-1138. PubMed ID: 28621623
[TBL] [Abstract][Full Text] [Related]
34. Disparities in receipt of modern concurrent chemoradiotherapy in glioblastoma.
Rhome R; Fisher R; Hormigo A; Parikh RR
J Neurooncol; 2016 Jun; 128(2):241-50. PubMed ID: 26970981
[TBL] [Abstract][Full Text] [Related]
35. Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma.
Sun MZ; Oh T; Ivan ME; Clark AJ; Safaee M; Sayegh ET; Kaur G; Parsa AT; Bloch O
J Neurosurg; 2015 May; 122(5):1144-50. PubMed ID: 25768833
[TBL] [Abstract][Full Text] [Related]
36. Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer.
Williams SB; Shan Y; Jazzar U; Mehta HB; Baillargeon JG; Huo J; Senagore AJ; Orihuela E; Tyler DS; Swanson TA; Kamat AM
JAMA Surg; 2018 Oct; 153(10):881-889. PubMed ID: 29955780
[TBL] [Abstract][Full Text] [Related]
37. Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis.
Reddy AK; Ryoo JS; Denyer S; McGuire LS; Mehta AI
Neurosurg Focus; 2019 Jun; 46(6):E3. PubMed ID: 31153148
[TBL] [Abstract][Full Text] [Related]
38. Patterns of Care and Outcomes of Hypofractionated Chemoradiation Versus Conventionally Fractionated Chemoradiation for Glioblastoma in the Elderly Population.
Haque W; Verma V; Butler EB; Teh BS
Am J Clin Oncol; 2018 Feb; 41(2):167-172. PubMed ID: 29369825
[TBL] [Abstract][Full Text] [Related]
39. Prognosis of Patients With Brainstem Glioblastoma Based on "age, surgery and radiotherapy": A SEER Database Analysis.
Li Y; Beeraka NM; Guo W; Lei Y; Hu Q; Guo L; Fan R; Liu J; Sui A
Technol Cancer Res Treat; 2022; 21():15330338221082760. PubMed ID: 35311589
[No Abstract] [Full Text] [Related]
40. Octreotide long-acting repeatable use among elderly patients with carcinoid syndrome and survival outcomes: a population-based analysis.
Shen C; Shih YC; Xu Y; Yao JC
Cancer; 2014 Jul; 120(13):2039-49. PubMed ID: 24676892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
